BOMPENBY Trademark

Trademark Overview

On Friday, April 8, 2022, a trademark application was filed for BOMPENBY with the United States Patent and Trademark Office. The USPTO has given the BOMPENBY trademark a serial number of 79340431. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by MABXIENCE RESEARCH, S.L.. The BOMPENBY trademark is filed in the Pharmaceutical Products category with the following description:

Biosimilar products for bone disease treatment, namely, biosimilar preparations for the treatment of osteoporosis, bone cancer, osteomyelitis, osteogenesis imperfecta, treatment of bone loss associated with hormonal suppression in men with prostate cancer at high risk of fractures, treatment of bone loss in men with prostate cancer undergoing hormonal suppression, and treatment to prevent risk of vertebral fractures
bompenby

General Information

Serial Number79340431
Word MarkBOMPENBY
Filing DateFriday, April 8, 2022
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7265232
Registration DateTuesday, January 9, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements

Goods and ServicesBiosimilar products for bone disease treatment, namely, biosimilar preparations for the treatment of osteoporosis, bone cancer, osteomyelitis, osteogenesis imperfecta, treatment of bone loss associated with hormonal suppression in men with prostate cancer at high risk of fractures, treatment of bone loss in men with prostate cancer undergoing hormonal suppression, and treatment to prevent risk of vertebral fractures
Translation of Words in MarkThe wording "BOMPENBY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMABXIENCE RESEARCH, S.L.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressES
Party NameMABXIENCE RESEARCH, S.L.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressES
Party NameMABXIENCE RESEARCH, S.L.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressES

Trademark Events

Event DateEvent Description
Wednesday, February 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 12, 2022SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, May 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 17, 2022APPLICATION FILING RECEIPT MAILED
Thursday, January 26, 2023ASSIGNED TO EXAMINER
Tuesday, January 31, 2023NON-FINAL ACTION WRITTEN
Monday, March 27, 2023REFUSAL PROCESSED BY MPU
Tuesday, March 28, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, April 19, 2023REFUSAL PROCESSED BY IB
Monday, September 18, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, September 18, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 18, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, September 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 19, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 19, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 19, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 18, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023NOTIFICATION PROCESSED BY IB
Monday, November 6, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, April 10, 2024FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, April 9, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 29, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 10, 2024FINAL DISPOSITION PROCESSED

Related Keywords

bompenby treatment bone cancer prostate biosimilar loss suppression fractures risk hormonal